Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 9/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.33 |
| ▸ | AHR | P35869 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | DHFR | P00374 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12259300 | 1.00 | SIGMAR1 (0.39) | SIGMAR1CYP1A2CYP2C19L3MBTL1AHR | |
| SCHEMBL18563220 | 0.92 | SIGMAR1 (0.33) | SIGMAR1CYP1A2CYP2C19L3MBTL1AHR | |
| SCHEMBL3854692 | 0.91 | SIGMAR1 (0.34) | SIGMAR1AHR | |
| SCHEMBL24277545 | 0.91 | SIGMAR1 (0.36) | SIGMAR1AHRKDM4E | |
| SCHEMBL24277572 | 0.91 | SIGMAR1 (0.36) | SIGMAR1AHRKDM4E | |
| SCHEMBL24277426 | 0.90 | SIGMAR1 (0.33) | SIGMAR1KDM4E | |
| SCHEMBL16787258 | 0.89 | SIGMAR1 (0.36) | SIGMAR1CYP1A2CYP2C19L3MBTL1AHR | |
| SCHEMBL24277624 | 0.87 | KDM4E (0.34) | SIGMAR1CYP1A2AHRKDM4E | |
| SCHEMBL13507663 | 0.86 | KDM4E (0.39) | SIGMAR1CYP1A2CYP2C19KDM4E | |
| SCHEMBL19588568 | 0.86 | KDM4E (0.39) | SIGMAR1CYP1A2CYP2C19KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2984079-B1 | HETEROCYCLIC COMPOUNDS AND THEIR USE IN ELECTRO-OPTICAL OR OPTO-ELECTRONIC DEVICES | POWER OLEDS LTD (GB) | 2020-07-01 | — | — | EP | disclosed |
| US-10439147-B2 | Heterocyclic compounds and their use in electro-optical or opto-electronic devices | POWER OLEDS LIMITED (GB) | 2019-10-08 | — | — | US | disclosed |
| CN-105189475-B | Heterocyclic compounds and their use in electro-optical or opto-electronic devices | 动力欧勒德斯有限公司 | 2018-12-21 | — | — | CN | disclosed |
| US-20180323378-A9 | HETEROCYCLIC COMPOUNDS AND THEIR USE IN ELECTRO-OPTICAL OR OPTO-ELECTRONIC DEVICES | POWER OLEDS LIMITED (GB) | 2018-11-08 | — | — | US | disclosed |
| EP-2984079-A2 | HETEROCYCLIC COMPOUNDS AND THEIR USE IN ELECTRO-OPTICAL OR OPTO-ELECTRONIC DEVICES | Power Oleds Limited (GB) | 2016-02-17 | — | — | EP | disclosed |
| US-20160035983-A1 | HETEROCYCLIC COMPOUNDS AND THEIR USE IN ELECTRO-OPTICAL OR OPTO-ELECTRONIC DEVICES | POWER OLEDS LTD (GB) | 2016-02-04 | — | — | US | disclosed |
| WO-2014167286-A2 | HETEROCYCLIC COMPOUNDS AND THEIR USE IN ELECTRO-OPTICAL OR OPTO-ELECTRONIC DEVICES | POWER OLEDS LIMITED (GB) | 2014-10-16 | — | — | WO | disclosed |
| US-8012606-B2 | Heterocyclic compound and organic electroluminescent device using the same | NIPPON STEEL CHEMICAL CO., LTD. (JP) | 2011-09-06 | — | — | US | disclosed |
| US-8012606-B2 | Heterocyclic compound and organic electroluminescent device using the same | NIPPON STEEL CHEMICAL CO., LTD. (JP) | 2011-09-06 | — | — | US | disclosed |
| US-8012606-B2 | Heterocyclic compound and organic electroluminescent device using the same | NIPPON STEEL CHEMICAL CO., LTD. (JP) | 2011-09-06 | — | — | US | disclosed |
| US-7605277-B2 | N,N'-Di(1-naphthyl)-N,N'-diphenyl-2,6-diaminodibenzodioxin; organic electroelement hole-transporting layer, light-emitting material, a host materialor dopant in the light-emitting layer,a hole-blocking layer, an electron-transporting layer;high luminous efficiency; high heat resistance; durability | NIPPON STEEL CHEMICAL CO., LTD. (JP) | 2009-10-20 | — | — | US | disclosed |
| US-7605277-B2 | N,N'-Di(1-naphthyl)-N,N'-diphenyl-2,6-diaminodibenzodioxin; organic electroelement hole-transporting layer, light-emitting material, a host materialor dopant in the light-emitting layer,a hole-blocking layer, an electron-transporting layer;high luminous efficiency; high heat resistance; durability | NIPPON STEEL CHEMICAL CO., LTD. (JP) | 2009-10-20 | — | — | US | disclosed |
| US-20090153031-A1 | Heterocyclic compound and organic electroluminescent device using the same | NIPPON STEEL CHEMICAL CO., LTD (JP) | 2009-06-18 | — | — | US | disclosed |
| US-20090153031-A1 | Heterocyclic compound and organic electroluminescent device using the same | NIPPON STEEL CHEMICAL CO., LTD (JP) | 2009-06-18 | — | — | US | disclosed |
| US-20090153031-A1 | Heterocyclic compound and organic electroluminescent device using the same | NIPPON STEEL CHEMICAL CO., LTD (JP) | 2009-06-18 | — | — | US | disclosed |
| US-20070129555-A1 | Aminodibenzodioxin derivative and organic electroluminescent using the same | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2007-06-07 | — | — | US | disclosed |
| US-20070129555-A1 | Aminodibenzodioxin derivative and organic electroluminescent using the same | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2007-06-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180323378-A9 | HETEROCYCLIC COMPOUNDS AND THEIR USE IN ELECTRO-OPTICAL OR OPTO-ELECTRONIC DEVICES | NAT1, SLCO2A1, SLCO2B1 | SIGMAR1 402/4885CYP1A2 296/4885CYP2C19 861/4885 |
| US-10439147-B2 | Heterocyclic compounds and their use in electro-optical or opto-electronic devices | NAT1, SLCO2A1, SLCO2B1 | SIGMAR1 402/4885CYP1A2 296/4885CYP2C19 861/4885 |
| US-20160035983-A1 | HETEROCYCLIC COMPOUNDS AND THEIR USE IN ELECTRO-OPTICAL OR OPTO-ELECTRONIC DEVICES | NAT1, SLCO2A1, SLCO2B1 | SIGMAR1 402/4885CYP1A2 296/4885CYP2C19 861/4885 |
| US-20090153031-A1 | Heterocyclic compound and organic electroluminescent device using the same | ORC3, NAP1L4, NR4A2 | SIGMAR1 1360/4885CYP1A2 1604/4885CYP2C19 2277/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.